While studying for her PhD at Leeds, UK Olga Kubassova began work on commercialising her research. She was the first winner of the Sir Peter Thompson Enterprise Award, and ten years on her bright idea has developed into a global business with HQ in London, UK and Philadelphia, USA. In this video, Olga talks about the encouragement she received in establishing the business, the fast growing team and endorsement from blue chip partners, which include top 10 pharmaceutical companies, innovative biotech and medtech players and IAG’s own portfolio companies.
Reach out to our expert team, as you are designing and planning your trial: imaging.experts@ia-grp.com
IAG is a unique partner to life sciences companies developing new treatment and driving the hope of the up-coming precision medicine. IAG leverages expertise in medical imaging and the power of DYNAMIKA™, our proprietary cloud-based platform, to de-risk clinical development and deliver lifesaving therapies into the hands of patients much sooner. IAG provides early drug efficacy assessments, smart patient recruitment and predictive analysis of advanced treatment manifestations, thus lowering investment risk and accelerating study outcomes.
Acting as imaging Contract Research Organization, IAG’s experts also recognize the significance of a comprehensive approach to asset development. They actively engage in co-development projects with both private and public sectors, demonstrating a commitment to cultivating collaboration and advancing healthcare solutions.
Contact our expert team: imaging.experts@ia-grp.com